- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/04 - Antibacterial agents
Patent holdings for IPC class A61P 31/04
Total number of patents in this class: 13854
10-year publication summary
|
491
|
523
|
879
|
1018
|
1191
|
1301
|
1245
|
1130
|
1275
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| King Faisal University | 821 |
214 |
| Glaxosmithkline Biologicals S.A. | 1696 |
127 |
| Centre National de La Recherche Scientifique | 10052 |
98 |
| The Regents of the University of California | 19479 |
95 |
| Pfizer Inc. | 3373 |
71 |
| Hoffmann-La Roche Inc. | 3252 |
62 |
| Intervet Inc. | 871 |
61 |
| iNtRON Biotechnology, Inc. | 177 |
61 |
| Novartis AG | 11297 |
60 |
| Intervet International B.V. | 1282 |
57 |
| Wockhardt Limited | 229 |
56 |
| Merck Sharp & Dohme LLC | 3742 |
53 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3353 |
52 |
| Daiichi Sankyo Company, Limited | 1863 |
47 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2581 |
44 |
| Shionogi & Co., Ltd. | 890 |
44 |
| President and Fellows of Harvard College | 5904 |
43 |
| F. Hoffmann-La Roche AG | 7942 |
40 |
| Board of Regents, The University of Texas System | 5604 |
38 |
| Mondobiotech Laboratories AG | 311 |
37 |
| Other owners | 12494 |